BGI 20 Kits for Mutation Detection of Human EGFR Gene

BGI 20 Kits for Mutation Detection of Human EGFR Gene

Product overview

The BGI 20 Kits for Mutation Detection of Human EGFR Gene is a BGI reagent kit listed within the Nucleic Acid Detection portfolio. The nucleic acid platform reagent uses the fluorescent quantitative PCR probe method to detect various bacterial, viral, and targeted drug mutation sequences, and has the advantages of high sensitivity, wide linear range, and more accurate quantification, which greatly shortens the detection window period. Pathogens can be detected in the early stage, allowing for earlier treatment.

Key features

• BGI-branded reagent kit for professional laboratory use
• Part of the Targeted Drug Guidance Examination Series product series
• Associated platform: Fluorescent quantitative PCR or nucleic-acid extraction, as applicable
• Available configuration and regulatory status may vary by market

Applications

Intended for professional laboratory testing related to 20 Kits for Mutation Detection of Human EGFR Gene. The exact specimen type, clinical indication and interpretation requirements depend on the registered configuration and local authorization.

Technical specifications

Ordering and configuration

Contact Scientific China for the current BGI catalog number, intended-use version, compatible platform, pack size, minimum order quantity, lead time, shipping conditions, certificates and formal quotation.